Clinical Trials Directory

Trials / Unknown

UnknownNCT02435368

The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear

The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and Lipopolysaccharide on Interleukin-1β Secretion by Mononuclear

Status
Unknown
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
The Third Affiliated Hospital of Southern Medical University · Other Government
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

To determine the mechanisms and significances of synergistic effects of mycophenolic acid and LPS on IL-1β secretion by mononuclear

Detailed description

Mycophenolate mofetil (MMF), which inhibits T and B lymphocyte proliferation, is widely used to treat a variety of autoimmune diseases, such as systemic lupus erythematosus (SLE) and lupus nephritis (LN). We are the first to show that mycophenolic acid (MPA), the active metabolite of MMF, in association with lipopolysaccharide (LPS), is able to promote the secretion of interleukin (IL)-1β, which contradicts the traditional conception that immunosuppressants inhibit the secretion of inflammatory factors. In this study, we first determined the effects of MPA in association with LPS on IL-1β production. Then, we explored whether the synergized effect on IL-1β production was mediated through the nuclear factor (NF)-κB pathway that produces more pro-IL-1β, or through the triggering of NLRP3 inflammasome that leads to enhanced activation of caspase-1 and accelerated degradation of pro-IL-1β into mature IL-1β. This study is not only conducive to clarify the mechanisms, signal transduction pathways and potential clinical significances of IL-1β production in LPS and MPA combined treatment, but also to provide experimental data as well as theoretical rationales for more effective and more logical immunosuppressive protocols.

Conditions

Interventions

TypeNameDescription
DRUGmycophenolic acidMonocytes were co-cultured with LPS and/or MPA.After 12 hours, the supernatants were harvested and stored at -80°C for ELISA.

Timeline

Start date
2015-04-01
Primary completion
2015-11-01
Completion
2016-03-01
First posted
2015-05-06
Last updated
2015-05-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02435368. Inclusion in this directory is not an endorsement.